Parabilis Medicines, Inc. (NASDAQ:PBLS) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$770.5M raised · US$20 a share · Leerink Partners +4 Dealers: Leerink Partners (co-lead), BofA Securities (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital | Jun 11, 2026 |
| Private placement of common stock Closed: US$75M raised · US$18 a share Buyers: Regeneron Pharmaceuticals, Inc. (4,166,666 shares of common stock at $18.00 per share) | Jun 11, 2026 |